Progesterone receptor membrane component 1: An integrative review

被引:295
作者
Cahill, Michael A. [1 ]
机构
[1] ProteoSys AG, D-55129 Mainz, Germany
关键词
membrane proteins; PGRMCI protein; receptors; progesterone; steroid; cholesterol; homology modelling; structure; models; molecular; molecular sequence data; protein binding; protein conformation; protein structure; tertiary; sequence homology; amino acid;
D O I
10.1016/j.jsbmb.2007.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progesterone receptor membrane component 1 (PGRMC1) contains a cytochrome b5 domain fold and belongs to the so-called membrane-associated progesterone receptor (MAPR) protein family that is widespread in eukaryotes. PGRMC1 and the related PGRMC2 mammalian family member diverged sometime after the evolution of segmented metazoan body plan and the appearance of vertebrates. Therefore PGRMC1 might be expected to be involved in some ancient eukaryotic processes, as well as more modern functions related to multicellularity and tissue interactions. Perhaps this explains the perplexing diversity of contexts where PGRMC1 has been observed, apparently being involved in different cellular processes at various sub-cellular locations. This review attempts to collate and interpret these observations. Ironically, despite being the archetypal member of the MAPR family, it has yet to be demonstrated that PGRMC1 exhibits specific progesterone binding. Potential roles of heme and steroid/sterol ligands are reviewed, as well as the implications of apparent target sequences within PGRMC1 for binding by SH2- and SH3-domain proteins as well as kinases. These motifs are modelled using the cytochrome b5 domain NMR structure of the Arabidopsis protein 1J03, implicating a possible function for PGRMC1 as an adaptor protein involved in regulating protein interactions and intracellular signal transduction and/or membrane trafficking. This interpretation is supported by the apparent presence of immunoreceptor tyrosine-based activation motif/ITAM sequences that are involved in endocytosis and vesicle targeting, and the colocalisation of PGRMC1 with caveolin and at the cytoplasmic membrane. Evidence for roles in disease, especially cancer, is also discussed. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:16 / 36
页数:21
相关论文
共 101 条
[1]   UNC-6/Netrin induces neuronal asymmetry and defines the site of axon formation [J].
Adler, CE ;
Fetter, RD ;
Bargmann, CI .
NATURE NEUROSCIENCE, 2006, 9 (04) :511-518
[2]   Netrin-1 and its receptors in tumorigenesis [J].
Arakawa, H .
NATURE REVIEWS CANCER, 2004, 4 (12) :978-987
[3]   Large-scale characterization of HeLa cell nuclear phosphoproteins [J].
Beausoleil, SA ;
Jedrychowski, M ;
Schwartz, D ;
Elias, JE ;
Villén, J ;
Li, JX ;
Cohn, MA ;
Cantley, LC ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12130-12135
[4]   The human membrane progesterone receptor gene: Genomic structure and promoter analysis [J].
Bernauer, S ;
Wehling, M ;
Gerdes, D ;
Falkenstein, E .
DNA SEQUENCE, 2001, 12 (01) :13-25
[5]   Non-genomic progesterone receptors in the mammalian ovary: some unresolved issues [J].
Bramley, T .
REPRODUCTION, 2003, 125 (01) :3-15
[6]   Non-genomic steroid receptors in the bovine ovary [J].
Bramley, TA ;
Menzies, GS ;
Rae, MT ;
Scobie, G .
DOMESTIC ANIMAL ENDOCRINOLOGY, 2002, 23 (1-2) :3-12
[7]   Recognition of a human sperm surface protein involved in the progesterone-initiated acrosome reaction by antisera against an endomembrane progesterone binding protein from porcine liver [J].
Buddhikot, M ;
Falkenstein, E ;
Wehling, M ;
Meizel, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :187-193
[8]   Inhibition of netrin-mediated axon attraction by a receptor protein tyrosine phosphatase [J].
Chang, C ;
Yu, TW ;
Bargmann, CI ;
Tessier-Lavigne, M .
SCIENCE, 2004, 305 (5680) :103-106
[9]   Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs [J].
Crudden, G ;
Chitti, RE ;
Craven, RJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :448-455
[10]   Overexpression of the cytochrome P450 activator Hr6 (heme-1 domain protein/hman progesterone receptor) in tumors [J].
Crudden, G ;
Loesel, R ;
Craven, RJ .
TUMOR BIOLOGY, 2005, 26 (03) :142-146